Completion of studies Sample Clauses

Completion of studies. The contract automatically ends after the successful completion of studies.
Sample 1Sample 2Sample 3See All (11)
AutoNDA by SimpleDocs
Completion of studies. 8.1 A Student who fails to complete her/his academic obligations during the duration of the academic program and receives written authorization from the Program Academic Director/Program Academic Committee to complete her/his studies the following year, can extend her/his degree, provided the program is still offered in the following year. For fees, please refer to section 2.5 above.
Sample 1Sample 2Sample 3See All (6)
Completion of studies. Degree programs completed with the presentation of the academic degree of Bachelor/Master of Arts in Business or Social Sciences. This can be abbreviated to BA/MA.
Sample 1Sample 2Sample 3See All (4)
Completion of studies. Courses and other academic activities for the doctoral student must meet the requirements of both programs in which he or she is enrolled and are subject to the regulations in place in the two institutions. To this end, the doctoral student shall participate in the following activities: (Specify the courses, seminars, examinations, etc., in which the doctoral student will participate in each institution) _____________________ University Academic activities: Université Laval Educational requirements for the program: Other academic activities:
Sample 1Sample 2
Completion of studies. 4.1.1 Pre-Clinical and Clinical Studies and Testing. Zonagen, at --------------------------------------------- its own cost and expense, shall diligently conduct and complete all ongoing (as of the Effective Date) testing and studies that are necessary or useful to support Regulatory Approval in the member states of the European Union as constituted on the Effective Date (the "European Union") of the Licensed Products for use in the Male Sexual Function Indication. Additionally, Zonagen shall diligently conduct and complete all testing and studies, including, without limitation, *** This portion has been omitted based on a request for confidential treatment pursuant to Rule 24b-2 of the Exchange Act. The omitted portion has been separately filed with the Commission. all post-marketing commitments, that are imposed by Regulatory Authorities or agreed to as a condition of Regulatory Approval of the Licensed Product with *** for use in the Male Sexual Function Indication, provided, however, -------- ------- that Zonagen's obligation to use such diligent efforts shall not be interpreted to require Zonagen to incur more than *** of expenses in conducting such studies. If the cost of such studies exceeds ***, the Parties shall mutually agree as to which Party shall complete and pay for such studies. Zonagen shall have no other right to conduct clinical studies of the Licensed Product or any Improvements thereto for use of such Licensed Product or Improvements in the Male Sexual Function Indication without first obtaining SP Ltd.'s written consent to conduct such clinical studies, which consent may be provided or withheld in SP Ltd.'s sole discretion. Should Zonagen fail to conduct any such studies within the time frame requested by Regulatory Authorities, SP Ltd. shall have the right to conduct such studies. SP Ltd. shall be permitted to credit the reasonably fully absorbed costs and expenses (directly attributed to the conduct of such studies) incurred by SP Ltd. in conducting such studies (including any payments SP Ltd. makes to Zonagen if Zonagen conducts such studies) against royalties that are or become due to Zonagen under Section 7.3 hereof, provided, however, that in no event shall such credit result in -------- ------- a reduction of more than *** of any royalty payment due under Section 7.3 hereof.
Sample 1
Completion of studies. Courses and other scheduled academic activities must meet the requirements of each of the programs and are subject to the regulations in force in both institutions. At Université Laval, the student specified in this agreement must register for each of the courses of his/her program, including the doctoral examination. Only research activities shall be shared between both institutions. The student specified in this agreement shall participate in the following activities: Partner institution: Specify the academic requirements (courses, seminars, exams and other academic activities): Université Laval: Specify the academic requirements (courses, seminars, exams and other academic activities):
Sample 1
Completion of studies. While undertaking his or her studies and research, the doctoral student shall alternate between the two universities for periods to be agreed upon in the nominate agreement. He or she must be enrolled full-time and attend each institution for at least three (3) terms in each institution. The normal length of a doctoral program is four (4) years.
Sample 1
AutoNDA by SimpleDocs

Related to Completion of studies

  • Completion of Project The Borrower shall carry out the Project in accordance with the Technical Description as may be modified from time to time with the approval of the Bank, and complete it by the final date specified therein.

  • Completion of the Project The Contracting Party shall complete the construction, equipping and furnishing of the Improvements in accordance with the Plans and submit to the Board a Certificate of Completion on or before November 1, 2016.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Completion of Due Diligence The Purchaser shall have completed all necessary due diligence investigations to its satisfaction.

  • Project Completion Part 1 – Material Completion

  • Completion of Repairs Borrower will commence any Repairs as soon as practicable after the date of this Loan Agreement and will diligently proceed with and complete such Repairs on or before the Completion Date. All Repairs and Capital Replacements will be completed in a good and workmanlike manner, with suitable materials, and in accordance with good building practices and all applicable laws, ordinances, rules, regulations, building setback lines and restrictions applicable to the Mortgaged Property. Borrower agrees to cause the replacement of any material or work that is defective, unworkmanlike or that does not comply with the requirements of this Loan Agreement, as determined by Lender.

  • EFFECT OF COMPLETION This agreement shall, as to any of its provisions remaining to be performed or capable of having or taking effect following Completion, remain in full force and effect notwithstanding Completion.

  • Substantial Completion “Substantial Completion” means the stage in the progress of the Work when the Work, or designated portions thereof, may still require minor modifications or adjustments but, in the Owner’s opinion, the Work has progressed to the point such that all parts of the Work under consideration are fully operational and usable for intended purposes, as evidenced by a Certificate of Substantial Completion approved by the Owner. If a Certificate of Occupancy is required by public authorities having jurisdiction over the Work, said certificate shall be issued before the Work or any portion thereof is considered substantially complete. When the Contractor considers that the Work, or a portion thereof which the Owner agrees to accept separately, is substantially complete, the Contractor shall notify Owner’s Designated Representative (sometimes referred to as the “ODR”) and request a determination as to whether the Work or designated portion thereof is substantially complete. If the ODR does not consider the Work substantially complete, the ODR will notify the Contractor giving reasons therefore. Failure on the Owner’s part to list a reason does not alter the responsibility of the Contractor to complete all Work in accordance with the terms of this Agreement. After satisfactorily completing items identified by Owner’s Designated Representative, the Contractor shall then submit another request for the ODR to determine Substantial Completion. If The ODR considers the Work substantially complete, The ODR will prepare and deliver a certificate of Substantial Completion which shall establish the date of Substantial Completion, shall include a punch list of items to be completed or corrected before final completion and final payment, shall establish the time within which the Contractor shall finish the punch list, and shall establish responsibilities of the Owner and the Contractor for security, maintenance, heat, utilities, damage to the Work, warranty and insurance. Failure to include an item on the punch list does not alter the responsibility of the Contractor to complete all Work in accordance with the terms and conditions of this Agreement. The certificate of Substantial Completion shall be signed by the Owner and the Contractor to evidence acceptance of the responsibilities assigned to them in such certificate. Substantial Completion (as defined in this agreement) for all stages of the Work shall be achieved on or before the following Substantial Completion date: DATE FOR SUBSTANTIAL COMPLETION: TBD Under no circumstances will the time for Substantial Completion exceed this date without a written amendment to this Agreement. THE TIMES SET FORTH IN THE CONSTRUCTION DOCUMENTS ARE AN ESSENTIAL ELEMENT OF THE AGREEMENT. TIME LIMITS STATED IN THE CONTRACT DOCUMENTS ARE OF THE ESSENCE OF THIS AGREEMENT.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Development of the Project 4.1 TSP's obligations in development of the Project: Subject to the terms and conditions of this Agreement, the TSP at its own cost and expense shall observe, comply with, perform, undertake and be responsible:

Time is Money Join Law Insider Premium to draft better contracts faster.